Randomized aldactone evaluation study (RALES) showed that adding aldosterone antagonist in the treatment of heart failure may decrease 30% mortality of all causes.
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
The concentration of serum adrenocorticotrophin(ACTH) and cortisol(F) were measured by RIA in 32 cases of male elderly patients with congestive heart failure and in 10 healthy men serving as controls.